HCV-话题@MedSci

#HCV#

247篇内容 | 3852人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257703, encodeId=0b85125e703da, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：Simeprevir, daclatasvir和sofosbuvir治疗HCV 基因1型感染患者的疗效和安全性, objectType=article, longId=125034, objectId=675212503410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=675212503410, replyNumber=0, likeNumber=61, createdTime=2017-12-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=675212503410, moduleTitle=J Viral Hepat：Simeprevir, daclatasvir和sofosbuvir治疗HCV 基因1型感染患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=675212503410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257702, encodeId=5458125e702cb, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：NS5A蛋白抑制剂对HCV基因1-7型的作用以及对逃逸变异的影响, objectType=article, longId=124775, objectId=b85a124e7526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b85a124e7526, replyNumber=0, likeNumber=92, createdTime=2017-12-28, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b85a124e7526, moduleTitle=Gastroenterology：NS5A蛋白抑制剂对HCV基因1-7型的作用以及对逃逸变异的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b85a124e7526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257701, encodeId=ebaf125e7018f, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：采用瞬时弹性成像预测HCV疾病进展到肝硬化的时间与肝纤维化进展率评估时间相似, objectType=article, longId=123942, objectId=2b601239427d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b601239427d, replyNumber=0, likeNumber=53, createdTime=2017-12-20, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b601239427d, moduleTitle=J Viral Hepat：采用瞬时弹性成像预测HCV疾病进展到肝硬化的时间与肝纤维化进展率评估时间相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b601239427d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257700, encodeId=3ea4125e700b4, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Eur J Gastroenterol Hepatol：血小板/淋巴细胞比率(PLR)是评估HCV患者存在显著肝纤维化或胰岛素抵抗的有用预测指标, objectType=article, longId=123940, objectId=90ff123940c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ff123940c1, replyNumber=0, likeNumber=87, createdTime=2017-12-20, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ff123940c1, moduleTitle=Eur J Gastroenterol Hepatol：血小板/淋巴细胞比率(PLR)是评估HCV患者存在显著肝纤维化或胰岛素抵抗的有用预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90ff123940c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257699, encodeId=ea2c125e69964, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：乙型肝炎病毒双重感染，阻碍了HCV患者治疗后血小板计数恢复, objectType=article, longId=123521, objectId=668f123521f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=668f123521f0, replyNumber=0, likeNumber=59, createdTime=2017-12-16, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=668f123521f0, moduleTitle=J Gastroenterol Hepatol：乙型肝炎病毒双重感染，阻碍了HCV患者治疗后血小板计数恢复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=668f123521f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257698, encodeId=26dd125e698a5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：HCV RNA清除改善了患者胰岛素抵抗, objectType=article, longId=123229, objectId=33b21232291d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33b21232291d, replyNumber=0, likeNumber=63, createdTime=2017-12-14, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33b21232291d, moduleTitle=J Gastroenterol Hepatol：HCV RNA清除改善了患者胰岛素抵抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33b21232291d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257697, encodeId=af7f125e697f0, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：HCV阳性肝移植到HCV阴性患者中的预后如何？, objectType=article, longId=123029, objectId=dd8c1230290f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd8c1230290f, replyNumber=0, likeNumber=60, createdTime=2017-12-13, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd8c1230290f, moduleTitle=Hepatology：HCV阳性肝移植到HCV阴性患者中的预后如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd8c1230290f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257696, encodeId=8ab8125e696d0, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：采用Sofosbuvir和Ribavirin治疗后，青少年HCV患者生活质量发生怎样的改变？, objectType=article, longId=122308, objectId=abca1223087e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abca1223087e, replyNumber=0, likeNumber=76, createdTime=2017-12-06, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abca1223087e, moduleTitle=J Viral Hepat：采用Sofosbuvir和Ribavirin治疗后，青少年HCV患者生活质量发生怎样的改变？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abca1223087e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257695, encodeId=bc7d125e6959f, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：国际间比较：在DAA治疗之前，HCV患者HCC发生率较高和存活率较低, objectType=article, longId=122213, objectId=31e91222138b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31e91222138b, replyNumber=0, likeNumber=85, createdTime=2017-12-05, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31e91222138b, moduleTitle=J Viral Hepat：国际间比较：在DAA治疗之前，HCV患者HCC发生率较高和存活率较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31e91222138b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257694, encodeId=3c09125e69429, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：抗HCV治疗后，5年肝脏硬度的改变, objectType=article, longId=121763, objectId=b403121e6321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b403121e6321, replyNumber=0, likeNumber=56, createdTime=2017-11-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b403121e6321, moduleTitle=J Gastroenterol Hepatol：抗HCV治疗后，5年肝脏硬度的改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b403121e6321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257693, encodeId=18b7125e6938d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：HBV与HCV联合感染阻断慢性丙型肝炎患者血小板计数恢复, objectType=article, longId=121755, objectId=20a1121e55f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20a1121e55f7, replyNumber=0, likeNumber=53, createdTime=2017-11-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20a1121e55f7, moduleTitle=J Gastroenterol Hepatol：HBV与HCV联合感染阻断慢性丙型肝炎患者血小板计数恢复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20a1121e55f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257692, encodeId=9f44125e6923b, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Gastroenterol Hepatol：HCV患者接受DAA治疗后产生早期病毒学反应的重要性, objectType=article, longId=121606, objectId=83901216066b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83901216066b, replyNumber=0, likeNumber=61, createdTime=2017-11-29, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83901216066b, moduleTitle=J Gastroenterol Hepatol：HCV患者接受DAA治疗后产生早期病毒学反应的重要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83901216066b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257691, encodeId=71b6125e69183, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat： HCV基因1、3型感染导致类似的脂肪变性, objectType=article, longId=121518, objectId=d7c21215185c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7c21215185c, replyNumber=0, likeNumber=65, createdTime=2017-11-28, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7c21215185c, moduleTitle=J Viral Hepat： HCV基因1、3型感染导致类似的脂肪变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7c21215185c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257690, encodeId=0bfc125e69088, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：低水平的硫酸脱氢表雄酮与HCV进展期肝纤维化相关, objectType=article, longId=121512, objectId=de4a12151294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de4a12151294, replyNumber=0, likeNumber=73, createdTime=2017-11-28, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de4a12151294, moduleTitle=J Viral Hepat：低水平的硫酸脱氢表雄酮与HCV进展期肝纤维化相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de4a12151294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257689, encodeId=a2e7125e689b1, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：Glecaprevir/Pibrentasvir治疗先前直接抗病毒治疗失败的HCV基因1型或4型患者, objectType=article, longId=121391, objectId=5d1812139172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1812139172, replyNumber=0, likeNumber=61, createdTime=2017-11-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1812139172, moduleTitle=Hepatology：Glecaprevir/Pibrentasvir治疗先前直接抗病毒治疗失败的HCV基因1型或4型患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1812139172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257688, encodeId=ee98125e6883e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：DAA对NS5A治疗失败的HCV患者再治疗，显示出良好效果, objectType=article, longId=121235, objectId=d57c1212356e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d57c1212356e, replyNumber=0, likeNumber=72, createdTime=2017-11-25, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d57c1212356e, moduleTitle=J Hepatol：DAA对NS5A治疗失败的HCV患者再治疗，显示出良好效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d57c1212356e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257687, encodeId=fa28125e6879b, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology ：DAA时代HCV/HIV共感染将不再难治, objectType=article, longId=119952, objectId=55701199525a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55701199525a, replyNumber=0, likeNumber=80, createdTime=2017-11-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55701199525a, moduleTitle=Hepatology ：DAA时代HCV/HIV共感染将不再难治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55701199525a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257686, encodeId=3d88125e686ca, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：每天三杯咖啡，HIV-HCV患者死亡率降低50%！, objectType=article, longId=114349, objectId=0f0b114349e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f0b114349e5, replyNumber=0, likeNumber=58, createdTime=2017-09-28, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f0b114349e5, moduleTitle=J Hepatol：每天三杯咖啡，HIV-HCV患者死亡率降低50%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f0b114349e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257685, encodeId=2cfb125e68585, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Hepatol：HCV清除减少了肝细胞癌发生的风险, objectType=article, longId=112653, objectId=c8061126539f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8061126539f, replyNumber=0, likeNumber=74, createdTime=2017-09-13, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8061126539f, moduleTitle=J Hepatol：HCV清除减少了肝细胞癌发生的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8061126539f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257684, encodeId=cf32125e684a1, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：HIV感染的患者中，细菌移位和HCV相关肝硬化的临床进展, objectType=article, longId=111993, objectId=ed86111993dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed86111993dc, replyNumber=0, likeNumber=120, createdTime=2017-09-06, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed86111993dc, moduleTitle=J Viral Hepat：HIV感染的患者中，细菌移位和HCV相关肝硬化的临床进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed86111993dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：Simeprevir, daclatasvir和sofosbuvir治疗HCV 基因1型感染患者的疗效和安全性

2017-12-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：NS5A蛋白抑制剂对HCV基因1-7型的作用以及对逃逸变异的影响

2017-12-28

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：采用瞬时弹性成像预测HCV疾病进展到肝硬化的时间与肝纤维化进展率评估时间相似

2017-12-20

ymljack (审核中...)

前往app查看评论内容

#HCV#

Eur J Gastroenterol Hepatol：血小板/淋巴细胞比率(PLR)是评估HCV患者存在显著肝纤维化或胰岛素抵抗的有用预测指标

2017-12-20

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：乙型肝炎病毒双重感染，阻碍了HCV患者治疗后血小板计数恢复

2017-12-16

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：HCV RNA清除改善了患者胰岛素抵抗

2017-12-14

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：HCV阳性肝移植到HCV阴性患者中的预后如何？

2017-12-13

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：采用Sofosbuvir和Ribavirin治疗后，青少年HCV患者生活质量发生怎样的改变？

2017-12-06

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：国际间比较：在DAA治疗之前，HCV患者HCC发生率较高和存活率较低

2017-12-05

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：抗HCV治疗后，5年肝脏硬度的改变

2017-11-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：HBV与HCV联合感染阻断慢性丙型肝炎患者血小板计数恢复

2017-11-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Gastroenterol Hepatol：HCV患者接受DAA治疗后产生早期病毒学反应的重要性

2017-11-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat： HCV基因1、3型感染导致类似的脂肪变性

2017-11-28

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：低水平的硫酸脱氢表雄酮与HCV进展期肝纤维化相关

2017-11-28

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：Glecaprevir/Pibrentasvir治疗先前直接抗病毒治疗失败的HCV基因1型或4型患者

2017-11-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：DAA对NS5A治疗失败的HCV患者再治疗，显示出良好效果

2017-11-25

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology ：DAA时代HCV/HIV共感染将不再难治

2017-11-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：每天三杯咖啡，HIV-HCV患者死亡率降低50%！

2017-09-28

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Hepatol：HCV清除减少了肝细胞癌发生的风险

2017-09-13

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：HIV感染的患者中，细菌移位和HCV相关肝硬化的临床进展

2017-09-06

科室
- - 订阅+
  - 更多科室
工具
服务